Audio
Archive
2013
January
February
March
April
May
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Jan. 25, 2008
Judah Folkman's Legacy
Click 
to enlarge images
to enlarge images
|
|
Tweet |
| Medical researcher Judah Folkman passed away last week at the age of 74. Until his death, he was Director of the Vascular Biology Program at Children's Hospital Boston. A central theme of his research was the idea of angiogenesis, the formation of new blood vessels. In 1971, Folkman published a paper in the New England Journal of Medicine arguing that angiogenesis was a key component in the growth of tumors. If a way could be found to limit the growth of blood vessels servicing a tumor, he reasoned, the tumor would be unable to grow. The idea has been incorporated into many differnt fields, and has led to the development of drugs such as Avastin (Bevacizumab), an angiogenisis inhibitor developed by Genentech. In this segment, we'll talk about Folkman's work and scientific legacy. |
Produced by Annette Heist, Senior Producer
Guests
-
Robert Cooke
Science Writer
Author, "Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer,"
(Random House, 2001)
Stow, Massachusetts -
Larry Norton
Deputy-in-Chief of Breast
Cancer Programs
Memorial Sloan-Kettering Cancer Center
New York, New York
FEATURED READING
Brilliant Blunders
by Mario Livio
ADVERTISEMENT
RELATED BLOG POSTS
- The Perils of Plankton
An artist magnifies an overlooked environmental problem in sculptures that are larger than life.
- Brilliant Blunders
Were the theories of illustrious minds such as Linus Pauling and Albert Einstein free of serious blunders? Absolutely not!
- Meet Susan Barry, Neurobiologist and 3D Visionary
Susan Barry could only see in two dimensions until age 48, when her life changed forever.
- Science Standards for the Next Generation
Newly released science standards expect students to be capable of designing experiments and making evidence-based arguments.
Discussion